Should the RAPIDO schedule represent standard of care in locally advanced rectal cancer?

Ann Oncol. 2022 Aug;33(8):745-746. doi: 10.1016/j.annonc.2022.05.002. Epub 2022 May 12.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Chemoradiotherapy
  • Humans
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / therapy
  • Rectum / pathology
  • Standard of Care*
  • Treatment Outcome